BriaCell Therapeutics Corp. (NASDAQ:BCTX) has a beta value of 0 and has seen 3,979,669 shares traded in the last trading session. The company, currently valued at $24.6 Million, closed the last trade at $3.69 per share which meant it gained $0.23 on the day or 6.49% during that session. The BCTX stock price is -250.95% off its 52-week high price of $12.95 and 19.78% above the 52-week low of $2.96. If we look at the company’s 10-day average daily trading volume, we find that it stood at 323.12 Million shares traded. The 3-month trading volume is 159.31 Million shares.
The consensus among analysts is that BriaCell Therapeutics Corp. (BCTX) is a 0 stock at the moment, with a recommendation rating of 0. None of the analysts rate the stock as a Sell, while none rate it as Overweight. None out of 0 have rated it as a Hold, with no one of them advising it as a Buy. None have rated the stock as Underweight.
BriaCell Therapeutics Corp. (NASDAQ:BCTX) trade information
Sporting 6.49% in the green in last session, the stock has traded in the green over the last five days, with the highest price hit on Friday, Apr 30 when the BCTX stock price touched $3.95-6 or saw a rise of 6.58%. Year-to-date, BriaCell Therapeutics Corp. shares have moved -11.51%, while the 5-day performance has seen it change 12.5%. Over the past 30 days, the shares of BriaCell Therapeutics Corp. (NASDAQ:BCTX) have changed 3.42%. Short interest in the company has seen 145.08 Million shares shorted with days to cover at 0.91.
BriaCell Therapeutics Corp. (BCTX) estimates and forecasts
Earnings growth for 2021 is a modest +0%.
BriaCell Therapeutics Corp. (NASDAQ:BCTX)’s Major holders
Insiders own 22.56% of the company shares, while shares held by institutions stand at 34.13% with a share float percentage of 44.07%. Investors are also buoyed by the number of investors in a company, with BriaCell Therapeutics Corp. having a total of 6 institutions that hold shares in the company. The top two institutional holders are Zeke Capital Advisors LLC with over 45Thousand shares worth more than $173.7 Thousand. As of March 30, 2021, Zeke Capital Advisors LLC held 0.71% of shares outstanding.